Ameriprise Financial Inc Macrogenics Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 80,878 shares of MGNX stock, worth $261,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,878

Previous 79,458 1.79%

Holding current value

$261,235

Previous $337,000 21.07%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $4,260 - $7,881	1,420 Added 1.79%	80,878 $266,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $85,523 - $478,261	25,838 Added 48.19%	79,458 $337,000
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $192,957 - $424,032	19,750 Added 58.31%	53,620 $789,000
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $29,290 - $66,099	6,538 Added 23.92%	33,870 $325,000
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $627 - $866	-140 Reduced 0.51%	27,332 $127,000
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $15,366 - $25,078	-3,326 Reduced 10.8%	27,472 $146,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $84,494 - $126,917	17,530 Added 132.12%	30,798 $220,000
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $44,315 - $92,610	13,268 New	13,268 $89,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $350,910 - $482,585	-22,056 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $54,028 - $78,551	-2,737 Reduced 11.04%	22,056 $462,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $2,376 - $4,133	-116 Reduced 0.47%	24,793 $666,000
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $21,477 - $37,549	1,131 Added 4.76%	24,909 $793,000
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $461,530 - $618,228	23,778 New	23,778 $544,000
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $9.67 Million - $54.1 Million	-1,859,098 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $2.04 Million - $5.77 Million	476,651 Added 34.48%	1,859,098 $10.8 Million
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $7.47 Million - $11.5 Million	-939,796 Reduced 40.47%	1,382,447 $15 Million
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $830,606 - $1.17 Million	-66,769 Reduced 2.79%	2,322,243 $29.6 Million
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $29 Million - $39.4 Million	1,997,327 Added 509.93%	2,389,012 $40.5 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $2.58 Million - $5.94 Million	-231,912 Reduced 37.19%	391,685 $7.04 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $851,264 - $1.55 Million	72,448 Added 13.14%	623,597 $7.92 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $940,042 - $1.15 Million	-48,808 Reduced 8.14%	551,149 $11.8 Million
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $3.22 Million - $4.02 Million	162,849 Added 37.26%	599,957 $12.4 Million
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $6.65 Million - $11.4 Million	352,214 Added 414.89%	437,108 $11 Million
Q4 2017 Feb 12, 2018	BUY	$16.19 - $20.3 $1.37 Million - $1.72 Million	84,894	84,894 $1.61 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Macrogenics Inc Transaction History